𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Thyroid dysfunction in laryngectomees—10 years after treatment

✍ Scribed by Ambrose Chung-Wai Ho; Wai-Kuen Ho; Paul Kin-Yip Lam; Anthony Po-Wing Yuen; William Ignace Wei

Book ID
102233519
Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
126 KB
Volume
30
Category
Article
ISSN
1043-3074

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Background.

Hypothyroidism is 1 of the complications that follow treatment of various head and neck cancers. In the literature, reviews using different primary sites and differences in treatment modalities make comparison of post‐treatment hypothyroidism not possible. The objective of this study was to evaluate the incidence of hypothyroidism in a homogenous group of patients who were treated with total laryngectomy and irradiation for laryngeal carcinoma and to assess the importance of different variables in the occurrence of hypothyroidism.

Methods.

A retrospective review of 147 total laryngectomy patients between 1993 and 2003 was carried out. Serum thyroxine level and free T4 levels were assessed in all patients. Hypothyroidism was classified as subclinical (increased thyroid‐stimulating hormone and normal free T4 levels) and clinical (increased thyroid‐stimulating hormone and decreased free T4 levels).

Results.

The results showed that the overall incidence of hypothyroidism was 49% (44% subclinical and 5% clinical). Hemithyroidectomy and advanced tumor staging were risk factors for the development of hypothyroidism in these patients (p < .05) with a relative risk of 2.1 (CI 95%, 1.4–3.1) and 1.3 (CI 95%, 1.1–1.6), respectively. During follow‐up, 19.9% of patients developed hypothyroidism at 3 years, 38.6% at 6 years; at 10 year follow‐up, 93.3% of them had hypothyroidism.

Conclusions.

In conclusion, hypothyroidism is a frequent complication in patients treated with radiotherapy and total laryngectomy for laryngeal cancer, especially when treatment includes hemithyroidectomy. These patients should have their thyroid function evaluated periodically even 10 years after treatment. © 2007 Wiley Periodicals, Inc. Head Neck 2008

📜 SIMILAR VOLUMES

Specific phobia 10–16 years after treatm
Specific phobia 10–16 years after treatment
✍ Joshua D. Lipsitz; Salvatore Mannuzza; Donald F. Klein; Donald C. Ross; Abby J. 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB 👁 1 views

Twenty eight participants, initially treated for specific phobia as part of a comparative treatment study, were evaluated 10 to 16 years (X = 12 years) later. A comprehensive, in-person, semi-structured diagnostic interview was utilized, which also assessed comorbid disorders. Of 21 patients who had

Renal function after 10 years' treatment
Renal function after 10 years' treatment with cyclosporin for psoriasis
✍ Powles; Hardman; Porter; Cook; Hulme; Fry 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 297 KB

Renal function was assessed by measuring serum creatinine and glomerular filtration rate (GFR) in two groups of patients with chronic plaque psoriasis who had been treated with cyclosporin A (CyA), average dose 2.8 mg/kg per day (range 1-5 mg/kg per day). Group I was our original cohort of nine pati